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 Abstract
Cutaneous metastasis may occur from different carcinomas. The most common carcinomas to metastasize 
to the skin are malignant melanoma and breast carcinoma. Breast cancer is the most common cause of 
skin metastases in female population. Cutaneous breast metastases are observed mainly on the chest 
wall but head and neck, are also common sites. The presence of skin metastases signifies widespread 
systemic disease and a poor prognosis for patients.
This article presents a case of an 86-year-old Caucasian woman who was treated in the hospital due 
to skin metastasis from breast cancer. The authors performed a literature review on skin metastases 
from breast cancer. 
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 Streszczenie
Przerzuty do skóry mogą wystąpić z różnych nowotworów. Najczęstszymi nowotworami dającymi prze-
rzuty do skóry są czerniak i rak piersi. Rak piersi jest najczęstszą przyczyną przerzutów do skóry wśród 
populacji kobiet. Przerzuty z raka piersi są głównie obserwowane w skórze klatki piersiowej, ale także w 
skórze głowy i szyi. Obecność przerzutów skórnych oznacza rozsianą chorobę nowotworową i złe roko-
wanie dla pacjentów.
W artykule przedstawiono przypadek 86-letniej kobiety rasy białej, która była leczona w szpitalu z powodu 
przerzutu raka piersi do skóry. Autorzy przeprowadzili przegląd piśmiennictwa na temat przerzutów raka 
piersi do skóry.
Słowa kluczowe: rak piersi, przerzut do skóry, leczenie
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Introduction
Cutaneous metastasis may occur from different carci-
nomas [1]. The most common carcinomas to metastasize 
to the skin are malignant melanoma and breast carcinoma 
[1, 2]. Breast cancer is the most common cause of skin 
metastases in female population [3]. Cutaneous breast 
metastases mainly are observed on the chest wall but 
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Figure 2. Cutaneous metastasis from breast carcinoma
Figure 3. Infiltration of malignant cells in the dermis (HE, 200x)
 
Figure 4. Tumour cells are positive to oestrogen receptors 
in 100% (100x)
Figure 5. Tumour cells are positive to progesterone receptors 
in 100% (100x)
were successfully treated with chemotherapy. The 
patient was treated with hormone therapy for five 
years. One year after hormone therapy, the patient 
has seen rapid growth of the skin tumour in the scalp 
of the head. She had no other symptoms; there was no 
history of weight loss or loss of appetite. The patient 
was treated chronically for ischaemic heart disease. 
She had negative family history for carcinoma. Blood 
test and other routine haematological examinations and 
biochemical tests were within normal limits.
In the Department of Surgical Oncology the patient 
underwent surgical resection of the skin tumour. Next day 
after the surgery, the patient left the department.
Pathological diagnosis showed skin metastasis from 
breast carcinoma (Figure 3). Tumour cells were ER (+) 
in 100% neoplasm cells, PR (+) in 100% neoplasm cells, 
CKAE1/AE3 (+), CK7 (+), CK20 (–), S-100 (–), TTF (–) and 
CDX-2 (–) (Figure 4–6).
Figure 1. The diameter of the skin tumour in palpable exam-
ination was 20 mm and it was located on the scalp
head and neck, are also common sites [4]. The presence 
of skin metastases signifies widespread systemic disease 
and a poor prognosis for patients.
Case report
An 86-year-old Caucasian woman was referred to the 
Department of Surgical Oncology due to skin tumour. 
The diameter of this tumour in palpable examination 
was 20 mm and it was located on the scalp of the head 
(Figure 1 and 2). The patient’s medical history revealed 
that six years ago she was treated for diagnosed with 
infiltrating ductal breast carcinoma and  successfully 
treated by mastectomy with axillary lymph node. She 
had a history of axillary lymph node metastases that 
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The patient is now under the care of oncological out-
patient clinic at our hospital. The patient has resumed 
hormone therapy and she feels good. Fourth months 
after surgery, there was no recurrence or metastasis.
Discussion
The skin metastases from internal malignancies are 
rare and were observed in up to 9% autopsies of cancer 
patients [5]. Metastasis is defined as a neoplastic lesion 
arising from another neoplasm with which it is no longer 
in contiguity or is not in close proximity with the same 
tissue [2]. In the majority of cases, skin metastases are 
from malignant melanoma and breast carcinoma [1, 2]. 
Skin metastases from carcinoma of the lung, oral cavity, 
stomach, colon, kidney and ovary have been observed [4].
Most cutaneous metastases are observed on the chest 
and abdomen wall but head and neck are also common 
sites [2, 4]. Metastases to extremities are rare [1, 2, 4]. 
Metastases in scalp associated with alopecia are known 
as Alopecia-neoplastica. 
Metastasis to the skin may be haematogenous or 
via lymphatics. Breast and oral cavity carcinoma spread 
(metastasize) via lymphatics. Solitary skin metastasis can 
be misdiagnosed as primary skin tumour [4]. Sometimes, 
skin metastases are observed before the symptoms of the 
primary disease occur [1, 2, 4]. There are many morpho-
logical variants of the skin metastases such as solitary or 
multiple erythematous infiltrating papules and nodules, 
carcinoma en cuirasse, alopecia neoplastica, carcinoma 
teleangiectaticum, inflammatory crease and zosteriform 
pattern [2, 3].
The skin metastases are treated locally or systemically 
[4, 5, 7, 8]. Surgical treatment together with hormone 
therapy, when ER/PR are positive, are acceptable as in 
this case. ER/PR- negative patients should be treated with 
systemic chemotherapy [7, 8].
The presence of skin metastases signifies widespread 
systemic disease and a poor prognosis for patients [3, 6]. 
Median overall survival in metastatic breast carcinoma is 
about 36 months [9]. In retrospective research by Hu et 
al., mean survival time in breast cancer patients with only 
cutaneous metastases was 57.43 months [10].
Diseases that should be consider in the differential 
diagnosis of skin metastases include: branchial cleft cyst, 
cellulitis, dermatofibroma, herpes zoster and pyogenic 
granuloma.
Conclusion
1. Cutaneous metastasis may derive from different car-
cinomas. 
2. In the majority of cases, skin metastases are from 
malignant melanoma and breast carcinoma.
3. Most cutaneous metastases are observed on the chest 
and abdomen wall.
4. The skin metastases should be treated locally or sys-
temically.
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Figure 6. Tumour cells are positive to CK7 (100x)
